Bin Feng
- Co-authors
- Kaiming SunJing WangLorenzo FedericoSridhar RamaswamyNingping FengJoseph R. MarszalekKeith MikuleGordon B. Mills
- Topics
- Multiple Sclerosis Research Studies (5 papers)PARP inhibition in cancer therapy (5 papers)Immunotherapy and Immune Responses (4 papers)
- Partner nations
- ChinaUnited StatesDenmark
In The Last Decade
Bin Feng
28 papers receiving 417 citations
Peers
Comparison fields: 5 of 81
- Oncology 203
- Molecular Biology 115
- Immunology 76
- Pharmacology 60
- Pulmonary and Respiratory Medicine 48
Countries citing papers authored by Bin Feng
This map shows the geographic impact of Bin Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Feng more than expected).
Fields of papers citing papers by Bin Feng
This network shows the impact of papers produced by Bin Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Feng. The network helps show where Bin Feng may publish in the future.
Co-authorship network of co-authors of Bin Feng
This figure shows the co-authorship network connecting the top 25 collaborators of Bin Feng. A scholar is included among the top collaborators of Bin Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bin Feng. Bin Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 7 | |
| 8 | 3 | |
| 9 | 5 | |
| 10 | 3 | |
| 11 | 6 | |
| 12 | 34 | |
| 13 | 13 | |
| 14 | 178 | |
| 15 | 2 | |
| 16 | 10 | |
| 17 | 9 | |
| 18 | 3 | |
| 19 | 5 | |
| 20 | 1 |
About Bin Feng
Bin Feng is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research, having authored 35 papers that have together received 431 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (5 papers), PARP inhibition in cancer therapy (5 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Oncology (203 citations), Reproductive Medicine (39 citations) and Immunology (76 citations). Bin Feng has collaborated with scholars based in China, United States and Denmark. Frequent co-authors include Kaiming Sun, Jing Wang, Lorenzo Federico, Sridhar Ramaswamy, Ningping Feng, Joseph R. Marszalek, Keith Mikule, Gordon B. Mills, Zebin Wang and Christopher P. Vellano. Their work appears in journals such as Journal of Clinical Oncology, ACS Nano and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.